Press Releases

12345678910
School Drillers Hits Milestone: Over 1 Million Learners Empowered with Free Educational Resources
School Drillers surpasses one million learners worldwide, delivering free, high-quality educational resources and advancing digital learning access across Africa and beyond through innovation and inclusive online education.
Via Press Release Distribution Service · January 9, 2026
PROPPAGANDA Launches Aerial Sessions 001, Taking Electronic Music 11,200 Feet Into the Sky
Extreme Sport DJ trades ocean depths for open air, suspending sound, risk, and purpose above Praia Grande
Via Press Release Distribution Service · January 9, 2026
Burcon Increases Non-Brokered Private Placement of Convertible Debentures to $6.9 Million
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global...
Via Newsfile · January 9, 2026
What If Gold Could Tell the Truth? Inside SMX's Vision for Tracking Precious Metals
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 9, 2026 / Gold has never been short on mystique. It appears polished and permanent, as if it's always existed exactly where you found it-on a ring, in a vault, behind glass at a jeweler's counter. But the reality is far messier. Before it becomes something beautiful or valuable, gold passes through mines, refineries, traders, borders, and buyers, often leaving very little evidence of where it's been or how it got there.
Via ACCESS Newswire · January 9, 2026
Ondas Holdings Inc. Successfully Prices $1 Billion Stock and Warrant Sale Above Market Price
WEST PALM BEACH, FLORIDA / ACCESS Newswire / January 9, 2026 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of autonomous aerial and ground robot intelligence through its Ondas Autonomous Systems (OAS) business unit and private wireless solutions through Ondas Networks, today announced that it has priced its $1 billion registered direct offering of 19,000,000 shares of its common stock and, in lieu of common stock, pre-funded warrants to purchase up to 41,790,274 shares of its common stock (together "Common Stock Equivalents") to an institutional investor. Each Common Stock Equivalent is being sold with a common stock warrant to purchase two (2) shares of common stock. The total number of Common Stock Equivalents to be sold in the offering is 60,790,274. The Common Stock Equivalents will be accompanied by warrants to purchase a total of 121,580,548 shares of common stock, which we refer to as common stock warrants.
Via ACCESS Newswire · January 9, 2026
Applied Energetics to Present at the 28th Annual Needham Growth Conference
TUCSON, AZ / ACCESS Newswire / January 9, 2026 / Applied Energetics, Inc. ("AE") (OTCQB:AERG), a leader in ultrashort pulse laser (USPL) and directed-energy technologies, today announced that it will participate and present at the 28th Annual Needham Growth Conference on January 15, 2026 at the Lotte New York Palace Hotel in New York City.
Via ACCESS Newswire · January 9, 2026
Curiteva Announces First Clinical Use of Inspire Standalone ALIF System
HUNTSVILLE, ALABAMA / ACCESS Newswire / January 9, 2026 / Curiteva, Inc., a leading technology and manufacturing company, proudly announces the first cases using its Inspire Standalone ALIF System. This milestone completes the company's anterior launch strategy and establishes the Inspire portfolio as a comprehensive, 360-degree solution for surgeons addressing spinal pathologies. This press release follows the recent publication of a peer-reviewed study in the Journal of Biomaterials, highlighting Curiteva's advancement in PEEK technology.
Via ACCESS Newswire · January 9, 2026
Late-Filed Returns Can Cancel Tax Relief Options - Clear Start Tax Warns Timing Matters More Than Amount Owed
Tax professionals say missing filing deadlines can quietly disqualify taxpayers from key IRS relief programs, even when balances are relatively small.
Via ACCESS Newswire · January 9, 2026
Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference
Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation in vivo CRISPR gene editing platform to create potential one-time curative therapies, today announced its participation in the upcoming 44th Annual J.P. Morgan Healthcare Conference.
By Mammoth Biosciences, Inc. · Via Business Wire · January 9, 2026
Gold Reserve Provides Update in Citgo Sale Process: Gold Reserve Files Appeal
Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that yesterday the Company filed its opening appeal brief with the U.S. Court of Appeals for the Third Circuit (the “Third Circuit”) in connection with the proposed judicial sale of PDVH Shares to Elliott/Amber Energy.
By Gold Reserve Ltd. · Via Business Wire · January 9, 2026
Bragg Gaming Further Extends PAM Agreement with Entain
Bragg Gaming Group (NASDAQ: BRAG, TSX: BRAG) (“Bragg” or the “Company”), a global iGaming content and technology supplier, is pleased to announce the extension of its existing Player Account Management (“PAM”) agreement with Entain Plc (LSE: ENTL), one of the world’s largest sports betting and gaming groups, for BetCity.nl, a leading Dutch market operator.
By Bragg Gaming Group Inc. · Via Business Wire · January 9, 2026
Bain Capital and BlueWater Marinas Acquire Kent Narrows Boatel
BlueWater Marinas (“BlueWater”) today announced the acquisition of Kent Narrows Boatel (“KNB”), a Class-A, heated drystack marina located just outside of Annapolis in Kent Narrows, MD. KNB will be the fourth marina added to the Bain Capital/BlueWater portfolio.
By Bain Capital Real Estate · Via Business Wire · January 9, 2026
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the completion of a Series F financing round in December 2025 led by Lightspeed Venture Partners. With $250M in new equity capital from its two most recent financing rounds, along with a 2025 amendment to its Silicon Valley Bank credit facility providing up to $100M in additional liquidity, Orca Bio possesses the financial strength to scale its commercial operations and advance its clinical pipeline.
By Orca Bio · Via Business Wire · January 9, 2026
Naveris® to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference
Naveris, Inc., the leader in precision oncology diagnostics for viral-driven cancers, today announced that it will be highlighting new data supporting the use of blood-based ctDNA tests to improve post-treatment surveillance protocols in both head-and-neck and anal cancers at the 44th Annual J.P. Morgan Healthcare Conference, to be held January 12-15, 2026, in San Francisco, CA.
By Naveris, Inc. · Via Business Wire · January 9, 2026
Lone Star Acquires Coral Gables Office Complex
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P., along with an affiliate of Highline Real Estate Capital LLC and Square2 Capital LLC, has successfully completed the acquisition of The Alhambra, an office complex in South Florida.
By Lone Star Funds · Via Business Wire · January 9, 2026
American Pacific Group Announces the Hire of Wyatt Brothers as a Principal
American Pacific Group (“APG”), a San Francisco Bay Area-based private equity firm, announced today that Wyatt Brothers has been hired as a Principal at the firm. He is focused on sourcing, executing, and supporting investments across the firm.
By American Pacific Group · Via Business Wire · January 9, 2026
Gold Reserve Announces Stock Option Grants
Gold Reserve Ltd. (TSX.V: GRZ) (BSX: GRZ.BH) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that it has granted a total of 1,525,000 stock options (the “Options”) to directors, officers, employees and certain key consultants of the Company. The Options are exercisable for a period of five years at an exercise price of US$3.64 per share. The Options were issued pursuant to the Company’s 2012 Equity Incentive Plan, as amended, and in accordance with the requirements of the TSX Venture Exchange and the Bermuda Stock Exchange.
By Gold Reserve Ltd. · Via Business Wire · January 9, 2026
Vivasure Medical Announces Acquisition by Haemonetics Corporation
Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the company has been acquired by Haemonetics Corporation (NYSE: HAE) in a transaction valued up to €185M (~$215M) on completion of certain milestones.
By Vivasure Medical · Via Business Wire · January 9, 2026
RADAR Names Former PVH/Lululemon Executive Jonathan Aitken to Lead RFID Center of Excellence
RADAR, the technology platform that leverages RFID overhead sensor technology to track and precisely locate in-store inventory with 99% accuracy across Old Navy, American Eagle and other top retailers, today announced three leadership appointments and several internal promotions to support growing customer demand and global expansion.
By RADAR · Via Business Wire · January 9, 2026
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating a scalable, federated framework designed to accelerate AI-enabled drug discovery.
By Revvity · Via Business Wire · January 9, 2026
AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD)
AirNexis Therapeutics, a clinical stage biotech company developing therapeutics for pulmonary diseases, today announced the close of a $200 million Series A financing round and the in-license of a dual PDE3/4 inhibitor in Phase 2 development for chronic obstructive pulmonary disease (COPD) from Haisco Pharmaceutical Group. The over-subscribed Series A was led by Frazier Life Sciences, with participation from OrbiMed, SR One, Life Sciences at Goldman Sachs Alternatives, Longitude Capital and Enavate Sciences among others. Proceeds of the financing will fund the global clinical development of AN01.
By AirNexis Therapeutics · Via Business Wire · January 9, 2026
Ouster Announces Participation in the 28th Annual Needham Growth Conference
Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a global leader in high-performance lidar sensors and intelligent software solutions that bring Physical AI to life across the automotive, industrial, robotics, and smart infrastructure sectors, today announced that Ouster management will participate in the upcoming investor event:
By Ouster, Inc. · Via Business Wire · January 9, 2026
Franklin Street Properties Corp. Declares Quarterly Dividend
Franklin Street Properties Corp. (“FSP”, “our” or “we”) (NYSE American: FSP) announced today that its Board of Directors declared a quarterly dividend of $0.01 per share of common stock for the period October 1, 2025 through December 31, 2025, payable on February 12, 2026 to stockholders of record as of January 23, 2026.
By Franklin Street Properties Corp. · Via Business Wire · January 9, 2026
Viper Partners Announces Major National Initiative to Fuel Dental Sector Resurgence in 2026
Viper Partners, the premier investment banking and M&A advisory firm specializing in dentistry since its founding in 2009, today announced a significant nationwide capital commitment aimed at accelerating mergers, acquisitions, and recapitalizations across the dental industry. With an unmatched track record of guiding hundreds of successful transactions, Viper is positioning 2026 as the pivotal year for dental practice owners to achieve optimal exits and for private equity firms to drive renewed growth.
By Viper Partners · Via Business Wire · January 9, 2026
Marqeta to Announce Fourth Quarter and Full Year 2025 Results on February 24, 2026
Marqeta, Inc. (NASDAQ: MQ), the global modern card issuing platform, today announced that it will host a conference call and webcast to discuss fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 4:30 pm ET. Hosting the call will be Mike Milotich, Chief Executive Officer and Patti Kangwankij, Chief Financial Officer. A press release with the fourth quarter and full year 2025 financial results will be issued after the market closes that same day.
By Marqeta · Via Business Wire · January 9, 2026
Global Mofy Announces Fiscal Year 2025 Financial Results; Conference Call Scheduled for Friday, January 9th, at 8:30 AM Eastern Time
BEIJING, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced its financial results for the fiscal year ended September 30, 2025.
By GLOBAL MOFY AI LIMITED · Via GlobeNewswire · January 9, 2026
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
-- Q4 2025 preliminary net product revenues from global sales of IMCIVREE® (setmelanotide) of approximately $57 million for the fourth quarter of 2025, an 11% increase over Q3 2025 --
By Rhythm Pharmaceuticals, Inc. · Via GlobeNewswire · January 9, 2026
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer
CAMBRIDGE, Mass., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for oncology and other therapeutic areas, today announced the appointment of Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer. Dr. Eck brings more than three decades of oncology drug discovery and development leadership across academia, biotechnology and large pharmaceutical companies.
By Flare Therapeutics Inc. · Via GlobeNewswire · January 9, 2026
Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy
Licensing of scientific discoveries from University of Cambridge and University of Edinburgh is aimed to speed translation and access to life-saving diagnostics for women worldwide.
By Medicines360 · Via GlobeNewswire · January 9, 2026
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
-- EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 --
By NewAmsterdam Pharma N.V. · Via GlobeNewswire · January 9, 2026
iAltA Holdings Acquires BridgeFT
Acquisition Strengthens Data Connectivity Across the Wealth and Private Markets Ecosystem
By iAltA · Via GlobeNewswire · January 9, 2026
HomeSphere and Associated Materials Innovations Partner to Support Residential Builders
Members gain access to savings on AMI brands Gentek® Building Products and ASCEND® Composite Cladding
By HomeSphere · Via GlobeNewswire · January 9, 2026
Crayhill and Monarch Launch Monarch JVT Funding to Provide $300 Million for Tax Credit Transfer Partnerships
ATLANTA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Crayhill Capital Management (“Crayhill”) and Monarch Private Capital (“Monarch”) are pleased to announce a strategic joint venture to facilitate hybrid preferred tax equity investments for renewable energy projects, including utility-scale solar, battery storage, and distributed generation projects. Crayhill has committed $300 million of capital into the joint venture, Monarch JVT Funding. Through Monarch’s best-in-class platform, the JV will invest in tax partnerships that will facilitate fair market value tax basis for renewable energy developers.
By Monarch Private Capital · Via GlobeNewswire · January 9, 2026
Rigetti Computing Provides Update on 108-Qubit System
BERKELEY, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced that it is revising its roadmap and adjusting the date for general availability of its 108-qubit quantum computing system, Cepheus™-1-108Q. Cepheus-1-108Q is now expected to reach general availability around the end of the first quarter of 2026.
By Rigetti Computing, Inc. · Via GlobeNewswire · January 9, 2026
Attindas Hygiene Partners Expands European Position with Key Acquisition
RALEIGH, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Attindas Hygiene Partners’ growth strategy realized an important step forward today with its acquisition of Societá Italiana Lavorazione Cellulosa (SILC S.p.A.). Attindas executed a share purchase agreement with SILC, acquiring all shares of the 53-year-old, family-owned company.
By Attindas Hygiene Partners · Via GlobeNewswire · January 9, 2026
NordPass launches Authenticator for personal accounts
LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- NordPass, a leading password manager, simplifies secure logins by including Authenticator on multiple devices in the application for personal use. The time-based one-time password (TOTP) support enables users to add an extra layer of security to their accounts with two-factor authentication, without the need to download or install additional applications. Authentication codes are synchronized within the account, letting users access them on both the mobile app or browser extension.
By NordPass · Via GlobeNewswire · January 9, 2026
Altus Group Announces Preliminary Results of Substantial Issuer Bid
TORONTO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced the preliminary results of its substantial issuer bid (the “SIB”), pursuant to which Altus Group offered to purchase for cancellation a number of its common shares (“Shares”) for an aggregate purchase price not to exceed C$350 million at a purchase price of not less than C$50.00 and not more than C$57.00 per Share. The SIB expired at 5:00 p.m. (Toronto time) on Thursday, January 8, 2026 (the “Expiration Time”).
By Altus Group Limited · Via GlobeNewswire · January 9, 2026
The Oncology Institute Announces Leadership Promotions
Rakesh Panda appointed Chief Information Officer
By TOI Management, LLC · Via GlobeNewswire · January 9, 2026
MidCap Financial Announces Inaugural Investment Grade Financing
$3.1 Billion Unsecured Funding Offering Strengthens Capital Structure and Marks Transformational Credit Profile Enhancement
By MidCap Financial Services, LLC · Via GlobeNewswire · January 9, 2026
Good Clashes With Evil In A Thrilling New Superhero Fiction Novel From Debut Author Ricky Burleson
Palmetto Publishing Announces the Release of KNIGHTSTORM
By Palmetto Publishing · Via GlobeNewswire · January 9, 2026
CANEX Metals Announces Significant Support for Its Offer to Purchase Shares of Gold Basin Resources, Extends Offer Until January 19, and Waives Minimum Tender Condition
CALGARY, AB / ACCESS Newswire / January 9, 2026 / CANEX Metals Inc. ("CANEX" or the "Company") (TSXV:CANX) is pleased to announce significant support for its Offer (the "Offer") to acquire all of the issued and outstanding common shares of Gold Basin Resources Corporation ("Gold Basin") (TSX.V:GXX) and has extended the Offer deadline to January 19th, 2026, as Gold Basin's lack of a transfer agent has resulted in challenges and delays for shareholders of Gold Basin ("Gold Basin Shareholders") to deposit to the Offer.
Via ACCESS Newswire · January 9, 2026
Kenorland Completes Top-Up Right from Sumitomo and Centerra
Vancouver, British Columbia--(Newsfile Corp. - January 9, 2026) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) ("Kenorland" or...
Via Newsfile · January 9, 2026
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations (microcystic LMs) remains on track, with topline results anticipated in March 2026; pending positive results, an NDA submission is planned for the second half of 2026
By Palvella Therapeutics Inc. · Via GlobeNewswire · January 9, 2026
AMC Robotics Showcases Kyro™ at CES 2026, Embodying the "ChatGPT Moment for Physical AI"
LAS VEGAS, Jan. 09, 2026 (GLOBE NEWSWIRE) -- AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), a leading AI-driven robotics solutions company, today announced its participation at CES® 2026. The Company demonstrated its latest artificial intelligence–powered technologies, headlined by Kyro™, its proprietary quadruped robotic platform.
By AMC Robotics Corporation · Via GlobeNewswire · January 9, 2026
Edible Garden Appoints Board Member Matthew McConnell as Executive Vice President, Strategic Partnerships
Seasoned Capital Markets and Financial Executive to Drive Strategic Growth and Market Expansion
By Edible Garden AG Incorporated · Via GlobeNewswire · January 9, 2026
Aircraft Machining Industry Research Report 2025: Segment Analysis, Regional Aircraft Projections, Defense Spending Trends, and Commercial & Business Jet Delivery Roadmaps 2019-2032 - ResearchAndMarkets.com
The "Aircraft Machining Market Size, Share, Trend, Forecast, Competitive Analysis, and Growth Opportunity: 2025-2032" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · January 9, 2026
Los Angeles Civil Litigation Lawyers Offer Practical Help In High-Stakes Cases
Los Angeles Civil Litigation Lawyers assist individuals and businesses involved in serious civil disputes. The firm offers practical guidance throughout the lawsuit process, helping clients understand their options and move cases toward resolution with steady legal support.
Via Press Release Distribution Service · January 9, 2026
O2B Kids Apopka Opens Today
APOPKA, Fla., Jan. 09, 2026 (GLOBE NEWSWIRE) -- O2B Early Education, a trusted leader in early childhood education, is proud to announce the opening of its 83rd location, O2B Kids Apopka, continuing its mission to inspire young learners and support families through high-quality, engaging early education.
By O2B Early Education · Via GlobeNewswire · January 9, 2026
Corporate Fleet Services Offers Citation Mustangs for Sale That Are True Very Light Jets, Built for Single-Pilot Operation, and Ideal for Medium Range Flight
Citation Mustang for Sale, Citation CJ2 for Sale, and Citation CJ3 for Sale. Citation JC3+ for Sale, Citation Jet for Sale, Citation CJ4 for Sale, and Private Planes for Sale.
Via ReleaseWire · January 9, 2026
Frost Insurance Shares Shocking Facts About Car Insurance
Car Insurance in Hamler, Bryan, OH, Defiance, OH, Napoleon, OH, Toledo, and Perrysburg. Affordable Auto Insurance, Affordable Car Insurance, Auto Insurance, and Motorcycle Insurance.
Via ReleaseWire · January 9, 2026